Cart
sales@molnova.com
Home - Products - Chromatin/Epigenetic - Bromodomain - ABBV-744

ABBV-744

CAS No. 2138861-99-9

ABBV-744 ( ABBV744 )

Catalog No. M13413 CAS No. 2138861-99-9

ABBV-744 (ABBV744) is a potent, BDII-selective BET bromodomain inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 In Stock
5MG 87 In Stock
10MG 138 In Stock
25MG 284 In Stock
50MG 410 In Stock
100MG 500 In Stock
200MG 718 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    ABBV-744
  • Note
    Research use only, not for human use.
  • Brief Description
    ABBV-744 (ABBV744) is a potent, BDII-selective BET bromodomain inhibitor.
  • Description
    ABBV-744 (ABBV744) is a potent, BDII-selective BET bromodomain inhibitor, ABBV-744 is a potent, selective inhibitor of the AR transcription activity; induces tumor growth inhibition in LNCaP and MDA-Pca-2b xenograft models.Prostate Cancer Phase 1 Clinical
  • Synonyms
    ABBV744
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    BET bromodomain
  • Research Area
    Cancer
  • Indication
    Prostate Cancer

Chemical Information

  • CAS Number
    2138861-99-9
  • Formula Weight
    491.56
  • Molecular Formula
    C28H30FN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM （ < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    O=C(C(N1)=CC(C(C2=CC(C(C)(O)C)=CC=C2OC3=C(C)C=C(F)C=C3C)=CN4C)=C1C4=O)NCC
  • Chemical Name
    1H-Pyrrolo[2,3-c]pyridine-2-carboxamide, N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(1-hydroxy-1-methylethyl)phenyl]-6,7-dihydro-6-methyl-7-oxo-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • MS645

    MS645 (MS-645) is a novel, bivalent bromodomain (BRD) inhibitor with Ki of 18.4 nM for tandem BD1-BD2 (BRD4 BD1/BD2 ).

  • Mivebresib

    Mivebresib (ABBV-075) is a potent and orally available BET bromodomain inhibitor with Ki of 1.0, 12.2, 1.5, and 2.2 nM for BRD2, BRD3, BRD4 and BRDT, respectively.

  • RVX2135

    RVX2135 is a novel potent and orally bioavailable inhibitor of Brd2, Brd3, Brd4, and BrdT.

Sign In Join Free